However, the human pancreatic neuroendocrine tumor cell line BON1 harbors a mutation in NRAS, while the human pancreatic neuroendocrine tumor cell line QGP-1 harbors a mutation in KRAS [38]. This evidence concerns the gene KRAS and pancreatic neuroendocrine tumor.